Replimune Group, Inc.
REPL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001737953
In the last 90 days, Replimune Group, Inc. insiders filed 0 open-market purchases and 5 sales; 199 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Replimune Group, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 110 | 101 | −9 |
| Shares | 34.9M | 35.4M | +487.4K (+1.4%) |
| Value | $1.34B | $1.05B | −$290.8M (−21.7%) |
New holders (5)
Institutions that held Replimune Group, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Frazier Management LLC | 491,998 | $14.6M | 1.17% |
| Prudential Financial Inc | 19,240 | $570.0K | 0.00% |
| Dynamic Technology Lab Private Ltd | 7,329 | $217.0K | 0.03% |
| Qube Research & Technologies Ltd | 7,131 | $211.0K | 0.00% |
| Point72 Hong Kong Ltd | 3,658 | $108.0K | 0.01% |
Sold out (14)
Institutions that held Replimune Group, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Corriente Advisors, LLC | 449,879 | $17.3M |
| Tekla Capital Management LLC | 219,060 | $8.42M |
| Point72 Asset Management, L.P. | 161,300 | $6.20M |
| Sofinnova Investments, Inc. | 71,661 | $2.75M |
| Squarepoint Ops LLC | 38,421 | $1.48M |
| AQR Capital Management LLC | 15,279 | $587.0K |
| AlphaCrest Capital Management LLC | 11,000 | $423.0K |
| Blueshift Asset Management, LLC | 7,868 | $302.0K |
| Arizona State Retirement System | 5,687 | $218.0K |
| Quantitative Systematic Strategies LLC | 5,517 | $212.0K |
| ExodusPoint Capital Management, LP | 5,408 | $208.0K |
| Lindbrook Capital, LLC | 1,400 | $54.0K |
| Quantbot Technologies LP | 1,400 | $53.0K |
| FORA Capital, LLC | 1,034 | $40.0K |